Overview
- 5 inspections across 3 sites are on record.
- 0 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2020-01-29.
At a glance
Inspections
5
Sites
3
Observations
0
Career since
Oct 2018
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Human Genome Sciences Inc | 29 Jan 2020 | Human Drugs | On file |
| Wyeth BioPharma Division of Wyeth Pharmaceuticals LLC | 3 May 2019 | Human Drugs | On file |
| FujiFilm Diosynth Biotechnologies U.S.A., Inc. | 1 Mar 2019 | Human Drugs | On file |
| FujiFilm Diosynth Biotechnologies U.S.A., Inc. | 22 Feb 2019 | Human Drugs | On file |
| FujiFilm Diosynth Biotechnologies U.S.A., Inc. | 26 Oct 2018 | Human Drugs | On file |
Sites inspected
Human Genome Sciences IncRockville, United States1 insp.
Wyeth BioPharma Division of Wyeth Pharmaceuticals LLCAndover, United States1 insp.
FujiFilm Diosynth Biotechnologies U.S.A., Inc.Research Triangle Park, United States3 insp.
Co-investigators
Investigators who share inspections with this person.
Full investigator report
Get the verbatim findings behind Amy A Devlin's inspection record
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site